Bone Morphogenetic Protein Market

Bone Morphogenetic Protein Market Size Survey Report – In a Glance

As per the survey report on global Bone morphogenetic protein market, the market is projected to foresee a CAGR of CAGR value 3.9% between 2024-2033, and further generate a market size of USD 465.5 Million revenue by the end of 2033. In the year 2023, the market size was valued at USD 342.2 Million revenue.

• The global Bone morphogenetic protein market is projected to grow on account of the growing number of sports injury cases.
• In Japan, the Bone morphogenetic protein market growth can be attributed to the government initiatives to modernize healthcare system.
• KDMI analyst’s growth analysis foresees expensive procedures to challenge the market growth.
• North America, having the highest market share in the Bone morphogenetic protein market, is projected to dominate the global market.

Bone Morphogenetic Protein Market Analysis

Bone morphogenetic proteins (BMPs) are a group of cell-signaling proteins essential in the formation of bones and cartilages that are a part of various cellular processes namely, differentiation, cell growth, and cell death. In the current era, the growing number of sports injury cases is giving a push to the bone morphogenetic protein market on a global scale. According to the National Safety Council (NSC) findings, an estimated 482,886 injuries occurred in 2023 due to sports or recreation activities. According to the National Highway Transportation Safety Administration (NHTSA), 1,105 pedal cyclists lost their lives in 2022, a 2.6 percent elevation from 2021. In 37% of all tragic accidents with pedal cyclists in 2022, alcohol was involved—either via the motor vehicle driver or the cyclist out of which 83% of fatal pedalcyclist crashes happened in urban areas. In accordance with a report in 2020, injuries increased by 20% in 2021, 12% in 2022, and now 2% in 2023. Around 3.7 million people were looked after in emergency departments for injuries involving sports and recreational equipment in 2023. The activities most commonly connected with injuries are exercise, cycling, and basketball. In 2023, the number of injuries increased by 8%, the age group with the highest injury rate is 15- to 24-year-olds, more males are injured than females, and 90% of injury victims are handled medically in emergency departments and released. Medtronic plc, Cellumed Co. Ltd., STEMCELL Technologies are some of the significant parties in the global market for Bone morphogenetic protein.

Analyst’s Observation on Japan Bone Morphogenetic Protein Market Survey

In Japan, the market growth for Bone morphogenetic protein can be attributed to the government initiatives to modernize healthcare system. Recently, the Government of Japan has been supporting the World Health Organization (WHO) by donating 19 mobile health and nutrition teams consisting of 132 multidisciplinary health workers providing essential health services including primary health care, maternal and child health care, mental health support, immunizations and nutritional care. Teams have contributed to more than 124,250 medical consultations, including healthcare referrals requiring specialized care and expert attention for patients. Another source indicates that the diagnostic and therapeutic AI healthcare tools market is likely to touch a number of around $114 million by 2027 in Japan. Medtronic, Cellumed Co.,Ltd, Sigma-Aldrich Corporation, are some of the significant parties in the market for Bone morphogenetic protein in Japan.

Bone Morphogenetic Protein Market Growth Driver and Challenges

Growth Driver

Technological advancements:

For the growth of a company or industry, research and development is a key factor and plays a crucial role in the market. Manufacturing businesses have carried out extensive research into the therapeutic potential of bone morphogenetic protein (BMP) in different orthopedic conditions, such as osteoarthritis and soft tissue healing. Moreover, the escalating knowledge on the subject of bone morphogenetic protein growth factor therapy is further anticipated to mitigate the growth of the bone morphogenetic protein market. In the Global Innovation Index 2024, Japan ranks 12th in innovation inputs and 14th in innovation outputs. In accordance with the Statistics Bureau of Japan reports, the total expenditure of the country on research and development during fiscal year (FY) 2022 was about 20.70 trillion yen, a 4.9 percent increase from the previous fiscal year which is the highest ever to date. Furthermore, the overall R&D funds spent in the three areas positioned by the Japanese government as fundamental technologies to be thoughtfully managed were 272.5 Million yen for AI, 385.0 Million yen for Biotechnology, and 132.2 Million yen for Quantum technology.

Restraint

Expensive procedures:

The high expenditure of the entire medical procedure is further expected to hamper the development of the bone morphogenetic protein market in the given timeline period. It was found that emergency general surgery (EGS) conditions contributed to around $28 Million in healthcare costs in the United States yearly. The 2023 Global Medical Trends Survey stated that the medical cost progression for 2023 is expected to continue at a relentlessly high global average of 10%, after rising from 8.2% in 2021 to a higher-than-anticipated 8.8% in 2022. Costs are predicted to continue surging in most regions. For instance, In Latin America, the medical trend is likely to soar from 18.2% to 18.9%, in Asia Pacific from 6.9% to 10.2%, and in the Middle East and Africa from 10.5% to 11.5%.

Bone Morphogenetic Protein Market Segmentation

Our experts at KD Market Insights have segmented the global Bone morphogenetic protein market research report as:

Bone Morphogenetic Protein Market Regional Synopsis

The North America Bone morphogenetic protein market is majorly driven by the increasing adoption of advanced technology, suitable reimbursement policies, early access to new products, rising healthcare infrastructure and increasing R&D initiatives. According to a recent report, osteoporosis is a major public health concern, affecting near about 40% of women over 70 years in the United Kingdom and about 55% of American citizens over the age of 50 are osteoporotic, with a significant proportion (80%) of these being female, in the United States. This is one of the chief reasons that encourage patients to look for surgical treatments like bone morphogenetic protein (BMP) procedure, which supports the development of the market in the region.

In contrast, the Asia-Pacific region is experiencing the quickest development due to growing medical tourism, an escalating economy, an increasing older population, and a huge patient population. Countries such as China and India are boosting the market further due to their Government’s efforts for healthcare advancements and expanding healthcare access within the country. The region is seeing excellent market growth greatly due to the increasing aging population where the number of older persons is supposed to be more than double, from 630 million in 2020 to about 1.3 Million by 2050. Moreover, about 13.6 percent of the population in Asia and the Pacific will be aged 60 years or over in 2020, and by 2050 it will be one-quarter of the population.

As per our analysts at KD Market Insights, the following five players lead the North America Bone morphogenetic protein market growth:

• Medtronic (US)
• Stryker Corporation (US)
• R&D Systems, Inc (US)
• Thermo Fisher Scientific (US)
• Akron Biotechnology LLC (US)

Bone Morphogenetic Protein Market Competitive Landscape

Some of the key players who top the global Bone morphogenetic protein market share:

• Medtronic (US)
• Johnson & Johnson
• Stryker Corporation (US)
• Merck KGaA (Germany)
• Prospec-Tany Technogene Ltd. (Israel)
• Ember Therapeutics. (US)
• R&D Systems, Inc (US)
• Thermo Fisher Scientific (US)
• Akron Biotechnology LLC (US)
• Sino Biological Inc (China)

1. Executive Summary
   1. Market Overview
   2. Key Findings
   3. Market Trends
   4. Market Outlook
2. Introduction
   1. Scope of the Report
   2. Research Methodology
   3. Definitions and Assumptions
   4. Acronyms and Abbreviations
3. Market Dynamics
   1. Drivers
   2. Restraints
   3. Opportunities
   4. Challenges
4. Global Bone Morphogenetic Protein Market
   1. Market Overview
   2. Market Size and Forecast
   3. Market Segmentation
      1. By Type
      2. By Application
      3. By End-user
      4. By Region
5. Market Segmentation by Type
   1. 1. Recombinant Bone Morphogenetic Proteins (rhBMPs)
      2. Synthetic Bone Morphogenetic Proteins
      3. Natural Bone Morphogenetic Proteins
6. Market Segmentation by Application
   1. 1. Orthopedic surgeries
      2. Dental surgeries
      3. Spinal surgeries
      4. Craniofacial surgeries
      5. Other applications
7. Market Segmentation by End-user
   1. 1. Hospitals
      2. Ambulatory surgical centers
      3. Research institutions
      4. Others
8. Regional Analysis
   1. North America
      1. United States
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type, Application, and End-user
      2. Canada
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type, Application, and End-user
      3. Mexico
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type, Application, and End-user
   2. Europe
      1. United Kingdom
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type, Application, and End-user
      2. Germany
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type, Application, and End-user
      3. France
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type, Application, and End-user
      4. Italy
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type, Application, and End-user
      5. Spain
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type, Application, and End-user
      6. Rest of Europe
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type, Application, and End-user
   3. Asia Pacific
      1. China
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type, Application, and End-user
      2. Japan
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type, Application, and End-user
      3. India
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type, Application, and End-user
      4. Australia
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type, Application, and End-user
         4. South Korea
         5. Market Size and Forecast
         6. Key Trends and Developments
         7. Market Analysis by Type, Application, and End-user
      5. Rest of Asia Pacific
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type, Application, and End-user
   4. Latin America
      1. Brazil
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type, Application, and End-user
      2. Argentina
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type, Application, and End-user
      3. Colombia
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type, Application, and End-user
      4. Rest of Latin America
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type, Application, and End-user
   5. Middle East & Africa
      1. South Africa
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type, Application, and End-user
      2. Saudi Arabia
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type, Application, and End-user
      3. UAE
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type, Application, and End-user
      4. Rest of Middle East & Africa
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type, Application, and End-user
9. Competitive Landscape
   1. Market Share Analysis
   2. Company Profiles
   3. Medtronic (Ireland)
   4. IBM
   5. Apple Inc.
   6. Siemens Medical Solutions
   7. Pepperl+Fuchs
   8. Cisco
   9. GE Healthcare
10. Strategic Recommendations
11. Appendix
    1. List of Tables
    2. List of Figures
12. References